A lot of plans dont cover weight management drugs or require prior authorization, so access is patchy
While initially approved for Type 2 diabetes, its increasingly prescribed off-label for weight loss due to its strong results
However, the path to mainstream adoption of GLP-1-enhancing beverages is not without challenges
In addition, the platform doesn't allow "trading, marketing, or providing access to regulated, prohibited, or high-risk goods and services," or directing users to third-party platforms to acquire such goods
This means even patients with modest weight loss experience meaningful cardiovascular benefits
What FDA's Public Guidance on Compounded GLP-1 Products Says - and How Consumers Can Use It as a Due-Diligence Framework FDA has publicly identified concerns involving unapproved and compounded GLP-1 products